Daiwa Securities Group Inc. Has $897,000 Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Daiwa Securities Group Inc. boosted its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 11.5% in the 4th quarter, HoldingsChannel.com reports. The fund owned 96,137 shares of the pharmacy operator’s stock after purchasing an additional 9,889 shares during the quarter. Daiwa Securities Group Inc.’s holdings in Walgreens Boots Alliance were worth $897,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of the stock. Brooklyn Investment Group raised its stake in Walgreens Boots Alliance by 21.1% during the fourth quarter. Brooklyn Investment Group now owns 4,757 shares of the pharmacy operator’s stock worth $44,000 after acquiring an additional 830 shares in the last quarter. First Financial Corp IN grew its holdings in shares of Walgreens Boots Alliance by 49.2% during the fourth quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock worth $25,000 after purchasing an additional 885 shares during the last quarter. CWA Asset Management Group LLC grew its holdings in shares of Walgreens Boots Alliance by 9.2% during the fourth quarter. CWA Asset Management Group LLC now owns 12,893 shares of the pharmacy operator’s stock worth $120,000 after purchasing an additional 1,084 shares during the last quarter. Metis Global Partners LLC grew its holdings in shares of Walgreens Boots Alliance by 4.9% during the fourth quarter. Metis Global Partners LLC now owns 23,815 shares of the pharmacy operator’s stock worth $222,000 after purchasing an additional 1,118 shares during the last quarter. Finally, Crestwood Advisors Group LLC grew its holdings in shares of Walgreens Boots Alliance by 6.3% during the fourth quarter. Crestwood Advisors Group LLC now owns 20,184 shares of the pharmacy operator’s stock worth $188,000 after purchasing an additional 1,199 shares during the last quarter. 58.59% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several analysts have recently commented on the company. Bank of America increased their target price on Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an “underperform” rating in a report on Monday, January 13th. Royal Bank of Canada increased their target price on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a “sector perform” rating in a report on Wednesday, January 15th. Truist Financial decreased their price target on Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating on the stock in a report on Friday, January 31st. Wolfe Research upgraded Walgreens Boots Alliance to a “hold” rating in a report on Monday, February 24th. Finally, Deutsche Bank Aktiengesellschaft cut Walgreens Boots Alliance from a “hold” rating to a “sell” rating and decreased their price target for the company from $11.00 to $9.00 in a report on Friday, February 28th. Four analysts have rated the stock with a sell rating, eight have assigned a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $11.54.

Walgreens Boots Alliance Trading Down 0.3 %

NASDAQ:WBA opened at $11.23 on Friday. Walgreens Boots Alliance, Inc. has a 1-year low of $8.08 and a 1-year high of $22.05. The business’s 50-day moving average price is $10.83 and its two-hundred day moving average price is $9.76. The company has a current ratio of 0.64, a quick ratio of 0.30 and a debt-to-equity ratio of 0.68. The firm has a market capitalization of $9.70 billion, a price-to-earnings ratio of -1.10, a PEG ratio of 1.31 and a beta of 0.62.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, topping analysts’ consensus estimates of $0.38 by $0.13. The company had revenue of $39.50 billion for the quarter, compared to analyst estimates of $37.40 billion. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. Walgreens Boots Alliance’s revenue was up 7.6% compared to the same quarter last year. During the same quarter last year, the firm posted $0.66 earnings per share. On average, equities analysts expect that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.